NCT04418180View on ClinicalTrials.gov

Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants

NACompletedINTERVENTIONAL
Timeline

Start Date

June 1, 2016

Primary Completion Date

December 12, 2018

Conditions
Neonatal Jaundice
Interventions
DRUG

Fenofibrate

Patients were randomly assigned to receive oral fenofibrate 10 mg/kg/hr

DRUG

Placebo

oral distilled water

All Listed Sponsors
lead

Mansoura University

OTHER

NCT04418180 - Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants | Biotech Hunter | Biotech Hunter